{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:04:08Z","timestamp":1790676248268,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015326","name":"NIH Common Fund","doi-asserted-by":"publisher","award":["UH2TR000943"],"award-info":[{"award-number":["UH2TR000943"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for RNA Interference, Non-Coding RNA"},{"name":"Ministry of Higher Education, Cultural Affairs, and Mission Sector"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.cellsig.2020.109539","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T11:10:12Z","timestamp":1578741012000},"page":"109539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0420-7191","authenticated-orcid":false,"given":"Amr Ahmed","family":"El-Arabey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Denizli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Kanlikilicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Recep","family":"Bayraktar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashwa","family":"Kabil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Ozpolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Calin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salama Abdou","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel Rashad","family":"Abd-Allah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0366-0720","authenticated-orcid":false,"given":"Gabriel","family":"Lopez-Berestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2020.109539_bb0005","doi-asserted-by":"crossref","first-page":"22832","DOI":"10.18632\/oncotarget.25126","article-title":"Role of tumor microenvironment in ovarian cancer pathobiology","volume":"9","author":"Ghoneum","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2020.109539_bb0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrclinonc.2015.224","article-title":"Can advanced-stage ovarian cancer be cured?","volume":"13","author":"Narod","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.cellsig.2020.109539_bb0020","article-title":"C\/EBP\u03b2 enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2020.109539_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10100366","article-title":"Bipolar tumor-associated macrophages in ovarian cancer as targets for therapy","volume":"10","author":"Gupta","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cellsig.2020.109539_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00137","article-title":"Tumor-associated macrophages contribute to tumor progression in ovarian cancer","author":"Colvin","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.cellsig.2020.109539_bb0040","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2020.109539_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0465-5","article-title":"Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein e","volume":"9","author":"Zheng","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2020.109539_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2018.00018","article-title":"Exosome-based cell-cell communication in the tumor microenvironment","volume":"6","author":"Maia","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity."},{"key":"10.1016\/j.cellsig.2020.109539_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.it.2014.04.002","article-title":"GATA3: a master of many trades in immune regulation","volume":"35","author":"Wan","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0065","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ni.1920","article-title":"The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection","volume":"11","author":"Satoh","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0070","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160105","article-title":"MicroRNA-720 suppresses M2 macrophage polarization by targeting GATA3","volume":"36","author":"Zhong","year":"2016","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cellsig.2020.109539_bb0075","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.18632\/aging.101929","article-title":"Aging and GATA3-positive macrophages","volume":"11","author":"Sharifi","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cellsig.2020.109539_bb0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ebiom.2018.11.004","article-title":"Exosomal miRNA confers chemo resistance via targeting Cav1\/p-gp\/M2-type macrophage axis in ovarian cancer","volume":"38","author":"Kanlikilicer","year":"2018","journal-title":"EBioMedicine."},{"key":"10.1016\/j.cellsig.2020.109539_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-Immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellsig.2020.109539_bb0090","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2020.109539_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: Implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0100","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","article-title":"Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin","volume":"158","author":"Hoadley","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2020.109539_bb0105","doi-asserted-by":"crossref","first-page":"497D","DOI":"10.1093\/nar\/gkh070","article-title":"Human protein reference database as a discovery resource for proteomics","volume":"32","author":"Peri","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2020.109539_bb0110","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2020.109539_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia."},{"key":"10.1016\/j.cellsig.2020.109539_bb0120","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2020.109539_bb0125","doi-asserted-by":"crossref","first-page":"43843","DOI":"10.18632\/oncotarget.5983","article-title":"CSIOVDB: A microarray gene expression database of epithelial ovarian cancer subtype","volume":"6","author":"Tan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2020.109539_bb0130","doi-asserted-by":"crossref","first-page":"D1140","DOI":"10.1093\/nar\/gku1092","article-title":"Cyclebase 3.0: A multi-organism database on cell-cycle regulation and phenotypes","volume":"43","author":"Santos","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2020.109539_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00421","article-title":"Macrophage polarization in the development and progression of ovarian cancers: an overview","volume":"9","author":"Cheng","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0140","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/cdd.2014.212","article-title":"A unique role for p53 in the regulation of M2 macrophage polarization","volume":"22","author":"Li","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2020.109539_bb0145","doi-asserted-by":"crossref","first-page":"17253","DOI":"10.1073\/pnas.1308887110","article-title":"Modulation of macrophage phenotype by cell shape","volume":"110","author":"McWhorter","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109539_bb0150","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/ni.2623","article-title":"GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling","volume":"14","author":"Wang","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102401","article-title":"The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: Biological pathways and therapeutic implication","volume":"20","author":"De Nola","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2020.109539_bb0160","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1002\/ijc.31750","article-title":"GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells","volume":"143","author":"Chen","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cellsig.2020.109539_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2020.109539_bb0170","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109539_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10110433","article-title":"Cell origins of high-grade serous ovarian cancer","volume":"10","author":"Kim","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cellsig.2020.109539_bb0180","doi-asserted-by":"crossref","first-page":"68033","DOI":"10.18632\/oncotarget.10797","article-title":"Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment","volume":"7","author":"Ciucci","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2020.109539_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/s18103249","article-title":"Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances","volume":"18","author":"Huang","year":"2018","journal-title":"Sensors (Switzerland)"},{"key":"10.1016\/j.cellsig.2020.109539_bb0190","doi-asserted-by":"crossref","first-page":"35944","DOI":"10.1074\/jbc.M109.091769","article-title":"Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides","volume":"285","author":"Dufour","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109539_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9653194","article-title":"EV-associated MMP9 in high-grade serous ovarian cancer is preferentially localized to annexin V-binding EVs","volume":"2017","author":"Reiner","year":"2017","journal-title":"Dis. Markers"},{"key":"10.1016\/j.cellsig.2020.109539_bb0200","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1128\/MCB.01549-13","article-title":"Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development","volume":"34","author":"Kitagawa","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0205","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1083\/jcb.200404018","article-title":"Integrin \u03b1v-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen","volume":"167","author":"Bao","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0210","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.21873\/anticanres.12745","article-title":"Mutant GATA3 actively promotes the growth of normal and malignant mammary cells","volume":"38","author":"Emmanuel","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cellsig.2020.109539_bb0215","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3892\/ijo.2017.3849","article-title":"LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K\/AKT pathway via di-demethylating H3K9 of cyclin D1","volume":"50","author":"Chen","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03224-w","article-title":"Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246","volume":"9","author":"Cooks","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2020.109539_bb0225","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41418-018-0246-9","article-title":"Mutant p53 as a guardian of the cancer cell","volume":"26","author":"Mantovani","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2020.109539_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10070219","article-title":"Role of p53 in the regulation of the inflammatory tumor microenvironment and tumor suppression","volume":"10","author":"Uehara","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cellsig.2020.109539_bb0235","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1158\/0008-5472.CAN-06-2425","article-title":"Mutant p53 enhances nuclear factor \u03baB activation by tumor necrosis factor \u03b1 in cancer cells","volume":"67","author":"Weisz","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2020.109539_bb0240","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-16-1996","article-title":"T-cell receptor signaling activates an ITK\/NF-\u03baB\/GATA-3 axis in T-cell lymphomas facilitating resistance to chemotherapy","volume":"23","author":"Wang","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2020.109539_bb0245","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/cas.12110","article-title":"Interaction of monocytes\/macrophages with ovarian cancer cells promotes angiogenesis in vitro","volume":"104","author":"Wang","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellsig.2020.109539_bb0250","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.14.1.34","article-title":"Regulation of tumor angiogenesis by p53-induced degradation of hypoxia- inducible factor 1\u03b1","volume":"14","author":"Ravi","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.cellsig.2020.109539_bb0255","doi-asserted-by":"crossref","first-page":"29409","DOI":"10.1074\/jbc.M502333200","article-title":"Ras-ERK MAPK cascade regulates GATA3 stability and Th2 differentiation through ubiquitin-proteasome pathway","volume":"280","author":"Yamashita","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109539_bb0260","doi-asserted-by":"crossref","first-page":"29109","DOI":"10.1074\/jbc.M109.041145","article-title":"Critical role for GATA3 in mediating Tie2 expression and function in large vessel endothelial cells","volume":"284","author":"Song","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109539_bb0265","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1038\/onc.2017.8","article-title":"GATA3 interacts with and stabilizes HIF-1\u03b1 to enhance cancer cell invasiveness","volume":"36","author":"Lin","year":"2017","journal-title":"Oncogene."},{"key":"10.1016\/j.cellsig.2020.109539_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00505","article-title":"Cellular phenotype plasticity in cancer dormancy and metastasis","volume":"8","author":"Yang","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2020.109539_bb0275","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3892\/or.2016.4729","article-title":"LSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion","volume":"35","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellsig.2020.109539_bb0280","doi-asserted-by":"crossref","first-page":"14042","DOI":"10.1074\/jbc.M110.105262","article-title":"GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition","volume":"285","author":"Yan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109539_bb0285","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ccr.2008.01.011","article-title":"GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model","volume":"13","author":"Kouros-Mehr","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2020.109539_bb0290","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1038\/s41388-019-0923-2","article-title":"LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression","volume":"38","author":"Hu","year":"2019","journal-title":"Oncogene."}],"updated-by":[{"DOI":"10.1016\/j.cellsig.2021.110147","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820300164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820300164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:53:53Z","timestamp":1760266433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656820300164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":58,"alternative-id":["S0898656820300164"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109539","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109539"}}